Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Marinelli

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 26, 2001
Current smoking, occupation, N-acetyltransferase-2 and bladder cancer: a pooled analysis of genotype-based studiesP Vineis, D Marinelli, H Autrup, et al.
Radiology|August 1, 1987
Prostatic disorders: MR imaging at 1.5 TM E Phillips, H Y Kressel, C E Spritzer, et al.
Lung Cancer (Amsterdam, Netherlands)|May 30, 2023
KRAS G12C mutation and risk of disease recurrence in stage I surgically resected lung adenocarcinomaF T Gallina, D Marinelli, E Melis, et al.
International Journal of Cardiology|October 23, 2024
Prognostic value of exercise tolerance and exercise-induced diastolic dysfunction in elderly patients referred for exercise stress echocardiographyChristopher N Matthews, Alaa Mabrouk Salem Omar, Mohammad I Khan, et al.
Biomarker Research|July 14, 2021
MicroRNA-based signatures impacting clinical course and biology of ovarian cancer: a miRNOmics studyE Krasniqi, A Sacconi, D Marinelli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 1, 2020
KEAP1-driven co-mutations in lung adenocarcinoma unresponsive to immunotherapy despite high tumor mutational burdenD Marinelli, M Mazzotta, S Scalera, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 5, 2024
Lung adenocarcinomas with mucinous histology: clinical, genomic, and immune microenvironment characterization and outcomes to immunotherapy-based treatments and KRAS<sup>G12C</sup> inhibitorsA Di Federico, L Hong, A Elkrief, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 26, 2001
Current smoking, occupation, N-acetyltransferase-2 and bladder cancer: a pooled analysis of genotype-based studiesP Vineis, D Marinelli, H Autrup, et al.
Radiology|August 1, 1987
Prostatic disorders: MR imaging at 1.5 TM E Phillips, H Y Kressel, C E Spritzer, et al.
Lung Cancer (Amsterdam, Netherlands)|May 30, 2023
KRAS G12C mutation and risk of disease recurrence in stage I surgically resected lung adenocarcinomaF T Gallina, D Marinelli, E Melis, et al.
International Journal of Cardiology|October 23, 2024
Prognostic value of exercise tolerance and exercise-induced diastolic dysfunction in elderly patients referred for exercise stress echocardiographyChristopher N Matthews, Alaa Mabrouk Salem Omar, Mohammad I Khan, et al.
Biomarker Research|July 14, 2021
MicroRNA-based signatures impacting clinical course and biology of ovarian cancer: a miRNOmics studyE Krasniqi, A Sacconi, D Marinelli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 1, 2020
KEAP1-driven co-mutations in lung adenocarcinoma unresponsive to immunotherapy despite high tumor mutational burdenD Marinelli, M Mazzotta, S Scalera, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 5, 2024
Lung adenocarcinomas with mucinous histology: clinical, genomic, and immune microenvironment characterization and outcomes to immunotherapy-based treatments and KRAS<sup>G12C</sup> inhibitorsA Di Federico, L Hong, A Elkrief, et al.
Pageof 4